Sen. Crapo: Republican Leaders Blast Unprecedented CMS Decision to Severely Limit Access to Lifesaving Cures
May 03, 2022
May 03, 2022
WASHINGTON, May 3 -- Sen. Mike Crapo, R-Idaho, issued the following news release:
Republican leaders of the Senate and House Committees with oversight of the Centers for Medicare and Medicaid Services (CMS) are raising concerns with a recent decision to severely restrict coverage of a U.S. Food and Drug Administration (FDA)-approved Alzheimer's treatment and any similar future treatments, in a disturbing break with precedent.
In a letter to CMS, Senate Finance Comm . . .
Republican leaders of the Senate and House Committees with oversight of the Centers for Medicare and Medicaid Services (CMS) are raising concerns with a recent decision to severely restrict coverage of a U.S. Food and Drug Administration (FDA)-approved Alzheimer's treatment and any similar future treatments, in a disturbing break with precedent.
In a letter to CMS, Senate Finance Comm . . .